31May 2023
Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin

Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin

This study investigated the impact of sulfatide on gene expression and proliferation of human primary fibroblasts stimulated by insulin, insulin-like growth factor-1, and human growth hormone. Human fibroblasts were treated with different concentrations of sulfatide or its precursor, galactosylceramide. The results showed that both sulfatide and GalCer reduced fibroblast growth by 32% to 82% when exposed to low insulin levels. Sulfatide also demonstrated a protective effect against membrane leakage induced by H2O2. Furthermore, sulfatide influenced gene pathways related to cell cycle/growth, transforming growth factor-β function, and intracellular signaling proteins. The study suggests that incorporating sulfatide into insulin formulations may benefit diabetic patients by suppressing adverse fibroblast growth and improving well-being.

  • #endo-diabetology

Like

Save

Share